Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d41a6a554a61e9119c13018acd485084 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-12 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00 |
filingDate |
2012-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70d1dc7b052019917656a6a20cadc5b6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3469b48c5f3c9baeb1658fd7014d3893 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c946a8893c1469a61f26f6c863a0e2d6 |
publicationDate |
2014-01-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-2679236-A1 |
titleOfInvention |
Metering guide for lipopeptides that bind endotoxin |
abstract |
The invention relates to an endotoxin-binding lipopeptide selected from the group consisting of polymyxins, polymyxin derivatives, polymyxin analogues, their prodrugs and their pharmaceutically acceptable salts and a preparation for parenteral administration comprising such a lipopeptide for the prophylaxis or treatment of diseases and conditions, by i) parenteral administration of a bolus of the lipopeptide to reach a serum lipopeptide concentration of 0.01 μg / ml to 0.8 μg / ml; and ii) maintenance of this lipopeptide serum concentration by parenteral administration of the lipopeptide a predetermined period. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107789691-A |
priorityDate |
2012-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |